Erythropoietin Drugs Market, By Type (Biologics, Biosimilars), By Product (Erythropoietin, Darbepoetin-alfa), By Application (Cancer, Renal Diseases, Neurology, Others), By Country, and By Region Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Erythropoietin drugs market size was valued at USD 7,008.1 Million in 2022, expanding at a CAGR of 10.5% from 2023 to 2030.
Erythropoietin (EPO) is also known as hematopoietin, a glycoprotein hormone secreted from the kidneys that play an important role in the development of red blood cells (RBCs) in the bone by stimulating the bone marrow tissues. Additionally, a rise in RBC count increases the hemoglobin level in the bloodstream and delivers a sufficient amount of oxygen to every part of the body. Moreover, erythropoietin medications are largely used in the treatment of anemia caused by end-stage renal disease (ESRD) and dialysis procedures.
Erythropoietin Drugs Market- Market Dynamics
The increasing prevalence of anemic conditions caused by ESRD treatment, antiretroviral treatment, and chemotherapy are major factors projected to increase the demand for the erythropoietin market. Additionally, besides treating anemia, several therapeutic advantages are associated with recombinant human erythropoietin such as brain disorders. Moreover, if erythropoietin is administered systematically, it passes the blood-brain barrier as a result improving neuroplasticity and rising cognitive functions in many brain disorders. However, the increasing cost of erythropoietin drugs is one of the major factors that could restrain the market growth during the forecast period.
Furthermore, increasing awareness regarding the advantages of erythropoietin therapeutics drugs, readily available reimbursements, and rising trends of commercialization for erythropoietin biosimilars are expected to boost the EPO drugs market growth. The covid-19 pandemic had a positive impact on the erythropoietin drugs market. It increased the demand for medicines and also increased the demand for various medical services. Additionally, the drug is helpful in anemia treatment and works against Covid-19.
Erythropoietin Drugs Market- Segmentation Analysis:
The global erythropoietin drugs market is segmented on the basis of type, product, application, and region.
The market is divided into two categories based on type: biologics and biosimilars. The biosimilars sector is likely to dominate the market. Due to the strong product pipeline, an increasing partnership among manufacturers & hospitals, and rising funds for development & research.
The market is divided into two categories based on product: erythropoietin and darbepoetin-alfa. The darbepoetin-alfa sector is expected to possess the market. This is partially due to darbepoetin-alfa helping in treating anemia that occurs in a patient who received chemotherapy for cancer.
The market is divided into three categories based on application: cancer, renal diseases, neurology, and others. The cancer sector is estimated to hold the largest market share during the forecast period. Cancer cases are increasing due to the adoption of alcohol, western lifestyle, smoking, and poor diet choice. Thus in turn propel the cancer segment growth.
Erythropoietin Drugs Market-Competitive Landscape:
The increasing demand for erythropoietin drugs thus increases the market growth globally. Additionally, market players are focusing on new product launches, partnerships, joint ventures, collaborations, and regional growth. Moreover, an increase in anemia in cancer patients boosted the erythropoietin drug market growth. Furthermore, strategies used by market players to strengthen and expand their business include R&D spending, mergers & acquisitions, and distribution channel development. For instance, in March 2022, Zydus Lifesciences a company received the new drug approval for Oxemia (Desidustat). Additionally, it is a first-of-its-kind oral treatment for anemia associated with chronic kidney disease(CKD), from the Drugs Controller General of India (DCGI).
Key features of the study:
- This proposed research study on erythropoietin drugs market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for erythropoietin drugs market.
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the erythropoietin drugs market.
- Impact of COVID-19 on erythropoietin drugs market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on erythropoietin drugs market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the erythropoietin drugs market, we have also included competitive landscape and key innovator analysis for the Erythropoietin Drugs Market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offersdetailed company profiling featuring major market participantswhich will help users to understand their financial information and strategic initiatives of players operating in the erythropoietin drugs market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global erythropoietin drugs market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ERYTHROPOIETIN DRUGS MARKET KEY PLAYERS
- AstraZeneca (U.K.)
- Lupin (India)
- Bristol-Myers Squibb Company (U.S.)
- Endo International plc (Ireland)
- JCR Pharmaceuticals Co., Ltd (Japan)
- Pfizer Inc (U.S.)
- Teva Pharmaceutical Industries Ltd (Israel)
- Sun Pharmaceutical Industries Ltd (India)
- Reddy's Laboratories Ltd (India)
- Mylan N.V. (U.S.)
- Novartis AG (Switzerland)
- Cipla Inc (India)
- Shanghai Dahua Pharmaceutical Co., Ltd (China)
GLOBALERYTHROPOIETIN DRUGS MARKET, BY TYPE
- Biologics
- Biosimilars
GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY PRODUCT
- Erythropoietin
- Darbepoetin-alfa
GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY APPLICATION
- Cancer
- Renal Diseases
- Neurology
- Others
GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Erythropoietin Drugs Market Overview
1.1. Study Scope
2. Executive Summary
2.1. Market Snippet
2.1.1. Erythropoietin Drugs Market Snippet by Type
2.1.2. Erythropoietin Drugs Market Snippet by Product
2.1.3. Erythropoietin Drugs Market Snippet by Application
2.1.4. Erythropoietin Drugs Market Snippet by Country
2.1.5. Erythropoietin Drugs Market Snippet by Region
2.2. Competitive Insights
3. Erythropoietin Drugs Key Market Trends
3.1. Erythropoietin Drugs Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Erythropoietin Drugs Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Erythropoietin Drugs Market Opportunities
3.4. Erythropoietin Drugs Market Future Trends
4. Erythropoietin Drugs Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Erythropoietin Drugs Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Erythropoietin Drugs Market Landscape
6.1. Erythropoietin Drugs Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Erythropoietin Drugs Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2022&2030 (%)
7.1.2. Biologics
7.1.3. Biosimilars
8. Erythropoietin Drugs Market – By Product
8.1. Overview
8.1.1. Segment Share Analysis, By Product, 2022&2030 (%)
8.1.2. Erythropoietin
8.1.3. Darbepoetin-alfa
9. Erythropoietin Drugs Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
9.1.2. Cancer
9.1.3. Renal Diseases
9.1.4. Neurology
9.1.5. Others
10. Erythropoietin Drugs Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Erythropoietin Drugs Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Erythropoietin Drugs Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Erythropoietin Drugs Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Erythropoietin Drugs Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Erythropoietin Drugs Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Erythropoietin Drugs Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. AstraZeneca (U.K.)
11.2.2. Lupin (India)
11.2.3. Bristol-Myers Squibb Company (U.S.)
11.2.4. Endo International plc (Ireland)
11.2.5. JCR Pharmaceuticals Co., Ltd (Japan)
11.2.6. Pfizer Inc (U.S.)
11.2.7. Teva Pharmaceutical Industries Ltd (Israel)
11.2.8. Sun Pharmaceutical Industries Ltd (India)
11.2.9. Dr. Reddy's Laboratories Ltd (India)
11.2.10. Mylan N.V. (U.S.)
11.2.11. Novartis AG (Switzerland)
11.2.12. Cipla Inc (India)
11.2.13. Shanghai Dahua Pharmaceutical Co., Ltd (China)
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
